Auris Medical : development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders like tinnitus and hearing loss

 

 

SEC Filing Details

Document Details

Form
F-1
Filing Date
Apr 29, 2020
Document Date
Apr 29, 2020
Form Description
Registration statement for certain foreign private issuers
Filing Group
Registration Statements
Company
Auris Medical Holding Ltd.

Investors